COMMUNIQUÉS West-GlobeNewswire

DiaMedica Therapeutics Announces Appointment of Scott Kellen as Chief Financial Officer
05/04/2018
MINNEAPOLIS, April 05, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ”) (TSX-V: DMA ) (OTCQB:DMCAF) is pleased to announce the appointment of Mr. Scott Kellen as Chief Financial Officer and [...]
Sonoma Pharmaceuticals Announces FDA Approval for Antimicrobial Post-Therapy Gel
05/04/2018
PETALUMA, Calif., April 05, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and markets unique and effective solutions for [...]
Summit Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
05/04/2018
Summit Therapeutics plc ("Summit", or the "Company") Summit Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference Oxford, UK, and Cambridge, MA, US, 5 April 2018 - Summit Therapeutics plc ( [...]
Summit Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
05/04/2018
OXFORD, United Kingdom, and CAMBRIDGE, Mass., April 05, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM) announces that Glyn Edwards, Chief Executive Officer, will present at the H.C. [...]
Antares Pharma Provides XYOSTED™ Regulatory Update
05/04/2018
Complete Response Resubmission Accepted – PDUFA Date September 29, 2018 EWING, N.J., April 05, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) (the Company) today announced that the U.S. Food and Drug [...]
Codexis to Present at H.C. Wainwright Global Life Sciences Conference in Monte Carlo, Monaco
05/04/2018
REDWOOD CITY, Calif., April 05, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a leading protein engineering company, announces that management will present at the H.C. Wainwright Global Life Sciences [...]
Stemline Therapeutics Announces Start of Rolling BLA Submission for SL-401
05/04/2018
NEW YORK, April 05, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that it has initiated its [...]
Avivagen Announces an Amendment to its Stock Option Plan
05/04/2018
OTTAWA, April 05, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, [...]
TRU NIAGEN® to be featured at the American Academy of Anti-Aging Medicine Spring Congress
05/04/2018
Keynote Speaker, Dr. Rudolph E. Tanzi, will sign copies of his new book, “The Healing Self,” at the TRU NIAGEN booth IRVINE, Calif., April 05, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), an integrated, [...]
Aino Health AB (publ): Aino Health launches work ability and health management service desk for managers
05/04/2018
Aino Health is launching a new service that will support managers as an effective first point of contact in daily activities regarding work ability and health management. Aino will offer the service as a multichannel [...]
Innovate Biopharmaceuticals, Inc. to Present at the H.C. Wainwright Annual Global Life Sciences Conference on April 9, 2018
05/04/2018
RALEIGH, N.C., April 05, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals (Nasdaq: INNT ), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases, [...]
PotNetwork Holdings, Inc. Moves Forward on OTCQB Uplist Process
05/04/2018
Company Contemplates Name Change to more closely align its corporate identity with becoming a dominant player in the rapidly-growing CBD industry FT LAUDERDALE, Fla., April 05, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE [...]
RadNet Becomes the Largest Outpatient Imaging Operator in the Greater Fresno, California Area with the Acquisition of Five Imaging Centers
05/04/2018
LOS ANGELES, April 05, 2018 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported it acquired [...]
Summit Therapeutics plc : Holding(s) in Company
05/04/2018
TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the [...]
AC Immune Announces the Selection of Tau Small Molecules for Clinical Development in Alzheimer's disease
05/04/2018
Tau small molecules (Tau Morphomers) demonstrate target-specific reduction of pathological Tau as well as cognitive and functional improvement Significant reduction of microglia activation enhances the benefits on Tau [...]
Elsalys Biotech : LEUKOTAC takes next step in paediatric acute steroid-resistant GvHD
05/04/2018
LEUKOTAC® takes next step in paediatric acute steroid-resistant GvHD ELSALYS BIOTECH plans to submit to the European Medicines Agency before summer 2018 a Paediatric Investigation Plan (PIP) proposing to conduct a [...]
Elsalys Biotech : LEUKOTAC, les prochaines étapes dans la GvHD aigüe et cortico-résistante en pédiatrie
05/04/2018
LEUKOTAC ® , les prochaines étapes dans la GvHD aigüe et cortico-résistante en pédiatrie ELSALYS BIOTECH prévoit de déposer avant l'été 2018 un plan d'investigation pédiatrique (PIP) auprès de l'Agence Européenne du [...]
Shire plc : Rule 2.9 Announcement
05/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 5 April 2018 Shire [...]
OSE Immunotherapeutics to Host Conference Call on April 5, 2018 to Discuss Boehringer Ingelheim Global Immuno-Oncology Partnership
05/04/2018
NANTES, France, April 05, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE), today announced that it will host an audio/web conference to discuss its global immuno-oncology partnership [...]

Pages